Prosecution Insights
Last updated: October 04, 2026

Applied Biocode Inc.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Applied Biocode Inc. currently has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This matter is assigned to 1 distinct examiner, TURPIN, ZACHARY MARK, who is also the busiest examiner for the company. The presence of a single pending office action indicates a focused prosecution stage. Since the portfolio is currently managed by 1 distinct examiner, the company's success in this technology area depends on addressing the specific concerns of this individual.

The portfolio is concentrated in 1 distinct art unit, which aligns with the single pending office action in Biotechnology & Pharmaceuticals. With TURPIN, ZACHARY MARK handling the 1 pending office action, there is no diversification across different art units or examiners at this time. The alignment of the pending workload with 1 distinct examiner and 1 distinct art unit suggests a very specific technical and procedural path for the company's current intellectual property. Practitioners should tailor their approach to the specific requirements of the assigned examiner.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
TURPIN, ZACHARY MARK 1 4.0% -5.0%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18225479 Method for Dynamic Range Expansion for Multiplex Assays TURPIN, ZACHARY MARK —

Top Art Units

Art UnitApps
1682 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18225479 Method for Dynamic Range Expansion for Multiplex Assays TURPIN, ZACHARY MARK 1682 §102§103§112 Non-Final OA — Pending Jul 24, 2023

Managing Applied Biocode Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month